XML 52 R26.htm IDEA: XBRL DOCUMENT
v3.25.1

Financial instruments by category | 12 Months Ended
--- | ---
Dec. 31, 2024
Disclosure of detailed information about financial instruments [abstract] |
Financial instruments by category | Financial instruments by category The Group classified its financial assets in the following categories: (a) Financial assets at fair value through profit or loss Financial assets at fair value through profit or loss are financial assets held for trading. A financial asset is classified in this category if acquired principally for the purpose of selling in the short-term. Derivatives are also categorized as held for trading unless they are designated as hedges. For all years presented, the Group’s financial assets at fair value through profit or loss comprise mainly short-term investment and derivative financial instruments. (b) Financial assets at amortized cost Financial assets at amortized cost, namely loans and receivables, are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. Loans and receivables comprise “trade and other receivables” and “cash and cash equivalents” in the statement of financial position. The following tables show the carrying amounts of financial assets and financial liabilities by category of financial instrument and reconciliation to the corresponding line item in the statements of financial position, as appropriate. Since the line items “Trade and other receivables, net” and “Trade and other payables” contain both financial instruments and non-financial assets or liabilities (such as other tax receivables or advance payments for services to be received in the future), the reconciliation is shown in the columns headed “Non-financial assets” and “Non-financial liabilities”.
| Financial assets at amortized cost |  | Financial assets at fair value through profit or loss |  | Subtotal financial assets |  | Non- financial assets |  | Total
December 31, 2024 |  |  |  |  |  |  |  |  |
Assets as per statement of financial position |  |  |  |  |  |  |  |  |
Trade and other receivables | 102,619 |  |  | — |  |  | 102,619 |  |  | 149,247 |  |  | 251,866 |
Derivative financial instruments | — |  |  | 9,596 |  |  | 9,596 |  |  | — |  |  | 9,596 |
Short term investment | — |  |  | 46,097 |  |  | 46,097 |  |  | — |  |  | 46,097 |
Cash and cash equivalents | 211,244 |  |  | — |  |  | 211,244 |  |  | — |  |  | 211,244 |
Total | 313,863 |  |  | 55,693 |  |  | 369,556 |  |  | 149,247 |  |  | 518,803 |
| Financial liabilities at amortized cost |  | Liabilities at fair value through profit or loss |  | Subtotal financial liabilities |  | Non- financial liabilities |  | Total
Liabilities as per statement of financial position |  |  |  |  |  |  |  |  |
Trade and other payables | 174,863 |  |  | — |  |  | 174,863 |  |  | 32,811 |  |  | 207,674 |
Borrowings | 779,556 |  |  | — |  |  | 779,556 |  |  | — |  |  | 779,556 |
Leases Liabilities | 342,030 |  |  | — |  |  | 342,030 |  |  | — |  |  | 342,030 |
Derivative financial instruments | — |  |  | 5,779 |  |  | 5,779 |  |  | — |  |  | 5,779 |
Total | 1,296,449 |  |  | 5,779 |  |  | 1,302,228 |  |  | 32,811 |  |  | 1,335,039 |
| Financial assets at amortized cost |  | Financial assets at fair value through profit or loss |  | Subtotal financial assets |  | Non- financial assets |  | Total
December 31, 2023 |  |  |  |  |  |  |  |  |
Assets as per statement of financial position |  |  |  |  |  |  |  |  |
Trade and other receivables | 113,831 |  |  | — |  |  | 113,831 |  |  | 104,284 |  |  | 218,115 |
Derivative financial instruments | — |  |  | 31,820 |  |  | 31,820 |  |  | — |  |  | 31,820 |
Short term investment | — |  |  | 62,637 |  |  | 62,637 |  |  | — |  |  | 62,637 |
Cash and cash equivalents | 339,781 |  |  | — |  |  | 339,781 |  |  | — |  |  | 339,781 |
Total | 453,612 |  |  | 94,457 |  |  | 548,069 |  |  | 104,284 |  |  | 652,353 |
| Financial liabilities at amortized cost |  | Liabilities at fair value through profit or loss |  | Subtotal financial liabilities |  | Non- financial liabilities |  | Total
Liabilities as per statement of financial position |  |  |  |  |  |  |  |  |
Trade and other payables | 163,481 |  |  | 1,400 |  |  | 164,881 |  |  | 26,857 |  |  | 191,738 |
Borrowings (i) | 904,949 |  |  | — |  |  | 904,949 |  |  | — |  |  | 904,949 |
Leases Liabilities | 378,510 |  |  | — |  |  | 378,510 |  |  | — |  |  | 378,510 |
Derivative financial instruments (i) | — |  |  | 169 |  |  | 169 |  |  | — |  |  | 169 |
Total | 1,446,940 |  |  | 1,569 |  |  | 1,448,509 |  |  | 26,857 |  |  | 1,475,366 |
(i) The Group formally documents and designates cash flow hedging relationships to hedge the foreign exchange rate risk of a portion of its highly probable future sales in U.S. Dollars using a portion of its borrowings denominated in U.S. Dollars, currency forwards and foreign currency floating-to-fixed interest rate swaps (See Note 2 for details). Because of the short maturities of most trade accounts receivable and payable, other receivables and liabilities, and cash and cash equivalents, their carrying amounts at the closing date do not differ significantly from their respective fair values. The fair value of long-term borrowings is disclosed in Note 26. Income, expense, gains and losses on financial instruments can be assigned to the following categories:
| Financial asset / liabilities at amortized cost |  | Assets/ liabilities at fair value through profit or loss |  |  |  | Total
December 31, 2024 |  |  |  |  |  |  |
Interest income (i) | 16,048 |  |  | — |  |  |  |  | 16,048 |
Interest expense (i) | (40,869) |  |  | — |  |  |  |  | (40,869) |
Foreign exchange loss (i) | (37,569) |  |  | — |  |  |  |  | (37,569) |
Gain from derivative financial instruments (ii) | — |  |  | 1,246 |  |  |  |  | 1,246 |
Finance cost related to lease liabilities | (32,938) |  |  | — |  |  |  |  | (32,938) |
| Financial assets / liabilities at amortized cost |  | Assets/ liabilities at fair value through profit or loss |  |  |  | Total
December 31, 2023 |  |  |  |  |  |  |
Interest income (i) | 7,134 |  |  | — |  |  |  |  | 7,134 |
Interest expense (i) | (31,906) |  |  | — |  |  |  |  | (31,906) |
Foreign exchange gains (i) | 90,930 |  |  | — |  |  |  |  | 90,930 |
Gain from derivative financial instruments (ii) | — |  |  | 10,414 |  |  |  |  | 10,414 |
Finance cost related to lease liabilities | (40,203) |  |  | — |  |  |  |  | (40,203) |
(i)Included in “Financial Results, net” in the consolidated statement of income. (ii)Included in “Other operating income, net” and “Financial Results, net” in the consolidated statement of income. Determining fair values IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. All financial instruments recognized at fair value are allocated to one of the valuation hierarchy levels of IFRS 13. This valuation hierarchy provides for three levels. The allocation reflects which of the fair values derive from transactions in the market and where valuation is based on models because market transactions are lacking. The level in the fair value hierarchy is categorized in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. As of December 31, 2024 and 2023, the financial instruments recognized at fair value on the statement of financial position comprise derivative financial instruments. In the case of Level 1, valuation is based on unadjusted quoted prices in active markets for identical financial assets that the Group can refer to at the date of the statement of financial position. The financial instruments the Group has allocated to this level mainly comprise crop futures and options traded on the stock market. Derivatives not traded on the stock market allocated to Level 2 are valued using models based on observable market data. The financial instruments the Group has allocated to this level mainly comprise interest-rate swaps and foreign-currency interest-rate swaps. In the case of Level 3, the Group uses valuation techniques not based on inputs observable in the market. This is only permissible insofar as no observable market data are available. The Group does not have financial instruments allocated to this level for any of the years presented. The following tables present the Group’s financial assets and financial liabilities that are measured at fair value as of December 31, 2024 and 2023 and their allocation to the fair value hierarchy:
|  |  | Level 1 |  | Level 2 |  | Total
Assets |  |  |  |  |  |  |
Derivative financial instruments | 2024 |  | 1,148 |  | 8,448 |  | 9,596 |
Short-term investment (1) | 2024 |  | 46,097 |  | — |  |  | 46,097 |
Derivative financial instruments | 2023 |  | 13,819 |  | 18,001 |  | 31,820 |
Short-term investment (2) | 2023 |  | 62,637 |  | — |  |  | 62,637 |
Liabilities |  |  |  |  |  |  |
Derivative financial instruments | 2024 |  | (2) |  |  | (5,777) |  |  | (5,779) |
Derivative financial instruments | 2023 |  | (68) |  |  | (101) |  |  | (169) |
(1) It includes US$ 1,474 of BOPREAL (Bonos para la Reconstrucción de una Argentina Libre) and US$ 44,623 of LECAPs (Letras del Tesoro Nacional Capitalizables en Pesos). (2) US-Treasury Bills with maturity from the date of acquisition longer than 90 days used as collateral for short-term borrowings. As of December, 2023, US$ 59,475 of these US T-bills are used as collateral for short-term borrowings and are not available for use by other entities of the Group. There were no transfers within level 1 and 2 during the years ended December 31, 2024 and 2023. When no quoted prices in an active market are available, fair values (particularly with derivatives) are based on recognized valuation methods. The Group uses a range of valuation models for this purpose, details of which may be obtained from the following table:
Class |  | Pricing Method |  | Parameters |  | Pricing Model |  | Level |  | 2024 |  | 2023
Futures |  | Quoted price |  | — |  | — |  | 1 |  | 852 |  | 8,657
Options/OTC |  | Quoted price |  | — |  | — |  | 1 |  | 160 |  | 5,141
NDF |  | Quoted price |  | Foreign-exchange curve |  | Present value method |  | 1 |  | 134 |  |  | (47) |
Interest-rate swaps |  | Theoretical price |  | Money market interest-rate curve |  | Present value method |  | 2 |  | 2,671 |  |  | 17,900 |
Public securities |  | Quoted price |  | — |  | — |  | 1 |  | 46,097 |  |  | 62,637 |

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Section Scope -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration